ABIGAIL CICHON: Open Payments
NPI 1790175800 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 60 payments from 14 companies in 2025. Trend: 2023 $978 · 2024 $884 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $317 |
| Novartis Pharmaceuticals Corporation | 13 | $224 |
| Novo Nordisk Inc | 8 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $89 |
| Lilly USA, LLC | 3 | $66 |
| Boston Scientific Corporation | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $32 |
Products named: LEQVIO, FARXIGA, Kerendia, AIRSUPRA, MOUNJARO, Ozempic, GEMTESA, Wegovy.
Industry payments across FL — which companies pay providers there.
